---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-081327"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2023-03-28T23:59:59+00:00"
generated_at: "2026-06-17T12:48:09.195473+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oscar Health appoints Mark Bertolini CEO; Schlosser moves to President of Technology

## Summary
- Mark Bertolini (ex-Aetna CEO) becomes CEO and board member effective April 3, 2023; Mario Schlosser transitions to President of Technology.
- Bertolini receives sign-on equity of 10.32M shares: 2.87M time-vested RSUs and 7.45M performance-vested PSUs with price targets of $11, $16, $39.
- Founders Schlosser and Kushner cancel their PSU awards (total 6.34M shares), triggering a ~$46M non-cash charge in Q1 2023.
- Inducement plan authorized shares increased from 5M to 18.32M to accommodate Bertolini's grants and annual employee awards.
- Company reaffirms full-year 2023 guidance as originally issued on February 9, 2023.

## SEC filing metadata
- accession: 0001193125-23-081327
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2023-03-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/0001193125-23-081327-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/d487122d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-081327
- JSON: https://secwatch.observer/filing/0001193125-23-081327.json
- Plain text: https://secwatch.observer/filing/0001193125-23-081327.txt

## Key facts
- Executive change
  Mark T. Bertolini was appointed as Chief Executive Officer at Oscar Health, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Mark T. Bertolini will join the Company as Chief Executive Officer and a member of the Company’s Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/0001193125-23-081327-index.htm
- Executive change
  Mario Schlosser changed role as President of Technology at Oscar Health, Inc..
  - Action: moved into the role of
  - Role: President of Technology
  source text: Co-founder Mario Schlosser will move into the role of President of Technology
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000119312523081327/0001193125-23-081327-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.